Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

<p><strong> Background</strong></p> Dexamethasone and remdesivir have the potential to reduce coronavirus disease 2019 (COVID)–related mortality or recovery time, but their cost-effectiveness in countries with limited intensive care resources is unknown. <p><strong&...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Jo, Y, Jamieson, L, Edoka, I, Long, L, Silal, S, Pulliam, JRC, Moultrie, H, Sanne, I, Meyer-Rath, G, Nichols, BE
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Oxford University Press 2021

Ижил төстэй зүйлс

The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing intensive care unit capacity
-н: Nichols, BE, зэрэг
Хэвлэсэн: (2020)

The National COVID-19 Epi Model (NCEM): estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
-н: Silal, SP, зэрэг
Хэвлэсэн: (2023)

The role of modelling and analytics in South African COVID-19 planning and budgeting
-н: Meyer-Rath, G, зэрэг
Хэвлэсэн: (2023)

Differential in-hospital mortality and intensive care treatment over time: informing hospital pathways for modelling COVID-19 in South Africa
-н: Jamieson, L, зэрэг
Хэвлэсэн: (2023)

Inpatient Care Costs of COVID-19 in South Africa’s Public Healthcare System
-н: Ijeoma Edoka, зэрэг
Хэвлэсэн: (2022-08-01)

Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa.
-н: Lise Jamieson, зэрэг
Хэвлэсэн: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting.
-н: Gesine Meyer-Rath, зэрэг
Хэвлэсэн: (2023-01-01)

The role of modelling and analytics in South African COVID-19 planning and budgeting
-н: Gesine Meyer-Rath, зэрэг
Хэвлэсэн: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa
-н: Sheetal Prakash Silal, зэрэг
Хэвлэсэн: (2023-01-01)

The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.
-н: Sheetal Prakash Silal, зэрэг
Хэвлэсэн: (2023-01-01)

Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
-н: Silal, SP, зэрэг
Хэвлэсэн: (2022)

Dexamethasone and remdesivir: finding method in the COVID-19 madness
-н: Pauline Vetter, зэрэг
Хэвлэсэн: (2020-12-01)

Cost utility analysis of Remdesivir and Dexamethasone treatment for hospitalised COVID-19 patients - a hypothetical study
-н: Andrea Carta, зэрэг
Хэвлэсэн: (2021-09-01)

Cancer mortality trends in South Africa: 1997 - 2016
-н: M L Nhleko, зэрэг
Хэвлэсэн: (2023-08-01)

A Retrospective Study of Dexamethasone, Remdesivir, and Baricitinib in Severe COVID-19
-н: Dallis Q. Ngo, зэрэг
Хэвлэсэн: (2022-01-01)

Pancreatic cancer mortality in South Africa: A case-control study
-н: M L Nhleko, зэрэг
Хэвлэсэн: (2023-12-01)

Cancer mortality distribution in South Africa, 1997–2016
-н: Mandlakayise Lucky Nhleko, зэрэг
Хэвлэсэн: (2023-06-01)

Costs of the COVID-19 vaccination programme: estimates from the West Rand district of South Africa, 2021/2022
-н: Ijeoma Edoka, зэрэг
Хэвлэсэн: (2024-07-01)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
-н: Gesine Meyer-Rath, зэрэг
Хэвлэсэн: (2021-07-01)

Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients
-н: Kaiyan Liu, зэрэг
Хэвлэсэн: (2023-03-01)

UPLC-PDA factorial design assisted method for simultaneous determination of oseltamivir, dexamethasone, and remdesivir in human plasma
-н: Hanan I. EL-Shorbagy, зэрэг
Хэвлэсэн: (2024-09-01)

Prognostic factors for poor outcomes in patients with severe COVID-19 treated with remdesivir plus dexamethasone in Taiwan
-н: Yi-Hsuan Lai, зэрэг
Хэвлэсэн: (2023-12-01)

Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness
-н: Youngji Jo, зэрэг
Хэвлэсэн: (2025-02-01)

Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa
-н: L. C. Long, зэрэг
Хэвлэсэн: (2023-03-01)

Modelling the Cost-Effectiveness of Hepatitis A in South Africa
-н: Jenna Patterson, зэрэг
Хэвлэсэн: (2024-01-01)

Death trends for 2010 - 2022 for members of a large private medical scheme in South Africa
-н: L Steenkamp, зэрэг
Хэвлэсэн: (2024-07-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data
-н: Mariet Benade, зэрэг
Хэвлэсэн: (2022-01-01)

Reduction in initiations of drug-sensitive tuberculosis treatment in South Africa during the COVID-19 pandemic: Analysis of retrospective, facility-level data.
-н: Mariet Benade, зэрэг
Хэвлэсэн: (2022-01-01)

Simultaneous HPLC determination of remdesivir and dexamethasone in the presence of metformin, sitagliptin, and glimepiride in a synthetic mixture and spiked human plasma
-н: Stanislav Bozhanov, зэрэг
Хэвлэсэн: (2024-03-01)

Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial
-н: Abu Taiub Mohammed Mohiuddin Chowdhury, зэрэг
Хэвлэсэн: (2022-04-01)

Healthcare costs of paternal depression in the postnatal period.
-н: Edoka, I, зэрэг
Хэвлэсэн: (2011)

Healthcare costs of paternal depression in the postnatal period
-н: Edoka, I, зэрэг
Хэвлэсэн: (2011)

Towards malaria elimination in Mpumalanga, South Africa: a population-level mathematical modelling approach.
-н: Silal, S, зэрэг
Хэвлэсэн: (2014)

The costs of interventions for type 2 diabetes mellitus, hypertension and cardiovascular disease in South Africa – a systematic literature review
-н: Sithabiso D. Masuku, зэрэг
Хэвлэсэн: (2022-12-01)

Attrition through multiple stages of pre-treatment and ART HIV care in South Africa.
-н: Matthew P Fox, зэрэг
Хэвлэсэн: (2014-01-01)

Clinical outcomes of remdesivir-treated COVID-19 patients in South Korea
-н: Mi Yu, зэрэг
Хэвлэсэн: (2022-10-01)

Exploring the seasonality of reported treated malaria cases in Mpumalanga, South Africa.
-н: Sheetal Prakash Silal, зэрэг
Хэвлэсэн: (2013-01-01)

Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered?
-н: Calvin Chiu, зэрэг
Хэвлэсэн: (2017-01-01)

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact
-н: Guillaume Béraud, зэрэг
Хэвлэсэн: (2022-01-01)

Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
-н: Guillaume Béraud, зэрэг
Хэвлэсэн: (2022-01-01)